Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)

China flag China · Delayed Price · Currency is CNY
14.17
+0.01 (0.07%)
Apr 29, 2026, 3:04 PM CST
3.73%
Market Cap 15.82B
Revenue (ttm) 2.66B
Net Income (ttm) 81.24M
Shares Out 1.12B
EPS (ttm) 0.07
PE Ratio 203.87
Forward PE 76.50
Dividend 0.04 (0.25%)
Ex-Dividend Date Jun 6, 2025
Volume 13,353,944
Average Volume 13,440,745
Open 14.27
Previous Close 14.16
Day's Range 13.97 - 14.27
52-Week Range 13.00 - 21.12
Beta 0.87
RSI 50.55
Earnings Date Apr 22, 2026

About SHE:300601

Shenzhen Kangtai Biological Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of human vaccines in China and internationally. The company offers 13-valent pneumococcal polysaccharide conjugate vaccines (TT/DT); varicella vaccines (freeze-dried); hepatitis B vaccines; 23-valent pneumococcal polysaccharide vaccines; diphtheria tetanus acellular pertussis and haemophilus influenzae type B combined vaccines; diphtheria, tetanus, and acellular pertussis combined vaccine, adsorbed; rabies v... [Read more]

Sector Healthcare
Founded 1992
Employees 1,913
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300601
Full Company Profile

Financial Performance

In 2025, SHE:300601's revenue was 2.67 billion, an increase of 0.81% compared to the previous year's 2.65 billion. Earnings were 70.33 million, a decrease of -65.12%.

Financial Statements

News

There is no news available yet.